A detailed history of Tradewinds Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 2 shares of VRTX stock, worth $942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 4 50.0%
Holding current value
$942
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$460.0 - $505.78 $920 - $1,011
-2 Reduced 50.0%
2 $0
Q2 2024

Jul 17, 2024

BUY
$392.81 - $485.53 $785 - $971
2 Added 100.0%
4 $1,000
Q1 2022

Apr 25, 2022

BUY
$221.42 - $260.97 $442 - $521
2 New
2 $1,000
Q4 2017

Feb 01, 2018

SELL
$137.28 - $155.55 $11,119 - $12,599
-81 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$148.13 - $162.24 $11,998 - $13,141
81
81 $12,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.